Deborah Villa

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Cancer Center of Kansas(Current)

Massachusetts General Hospital

University of California, Los Angeles

Deborah Villa is an author at Cancer Center of Kansas specializing in her2-positive breast cancer therapy, her2-positive breast cancer immunotherapy, and immunotherapy.

Publications per year

2022–2023

Publications

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.

Sara A. Hurvitz, Lisa S. Wang, David W. Chan et al. · Journal of Clinical Oncology · 2022 · 39 citations

Medicine, Pharmacology, Chemotherapy +16

Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

Aditya Bardia, Sara A. Hurvitz, Michael F. Press et al. · Cancer Research · 2023 · 31 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2